[go: up one dir, main page]

KR970701535A - 비타민 E를 함유하는 에어로졸 약물 제형(Aerosol drug formulations containing vitamin'E) - Google Patents

비타민 E를 함유하는 에어로졸 약물 제형(Aerosol drug formulations containing vitamin'E)

Info

Publication number
KR970701535A
KR970701535A KR1019960705052A KR19960705052A KR970701535A KR 970701535 A KR970701535 A KR 970701535A KR 1019960705052 A KR1019960705052 A KR 1019960705052A KR 19960705052 A KR19960705052 A KR 19960705052A KR 970701535 A KR970701535 A KR 970701535A
Authority
KR
South Korea
Prior art keywords
tocopherol
pharmaceutical composition
alpha tocopherol
propellant
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019960705052A
Other languages
English (en)
Inventor
지울리아노 페트렐리
루 모우-잉 후
프라모드 케이 거프타
애크위트 엘 애드제이
Original Assignee
지울리아노 페트렐리
브룩 찰스 엠
애보트 래보러토리즈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 지울리아노 페트렐리, 브룩 찰스 엠, 애보트 래보러토리즈 filed Critical 지울리아노 페트렐리
Publication of KR970701535A publication Critical patent/KR970701535A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

(a) 약제, (b) 비-클로로플루오로카본 분사제 및 (c) 토코페롤 또는 이의 약제학적으로 허용되는 유도체를 포함하는 에어로졸 운반용 약제학적 조성물 뿐만 아니라, 약제의 바람직하지 않은 응집이 계면활성제 또는 보조용매를 사용하지 않고 방지되는 조성물의 제조방법이 기술되어 있다.

Description

비타민 E를 함유하는 에어로졸 약물 제형 (Aerosol drug formulations containing vitamin E)
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (14)

  1. 약제, 비-클로로플루오로카본 분사제 및 토코페롤을 포함하는 에어로졸 운반용 약제학적 조성물.
  2. 제1항에 있어서, 분사제가 할로겐화 알칸인 약제학적 조성물.
  3. 제2항에 있어서, 분사제가 HFC-134a 및 HFC-227ea로 이루어진 그룹중에서 선택된 약제학적 조성물.
  4. 제2항에 있어서, 토코페롤이 d-알파 토코페롤, dl-알파 토코페롤, d-알파 토코페롤 아세테이트, dl-알파 토코페롤 아세테이트, d-알파 토코페롤산 석시네이트 및 dl-알파 토코페롤산 석시네이트로 이루어진 그룹중에서 선택된 형태로 존재하는 약제학적 조성물.
  5. 제1항에 있어서, 토코페롤이 0.00001 내지 10중량%의 농도로 존재하는 약제학적 조성물.
  6. 제1항에 있어서, 토코페롤이 0.001 내지 5중량%의 농도로 존재하는 약제학적 조성물.
  7. 제3항에 있어서, 약제가 LHRH 동족체, 5-리폭시게나제 억제제, 면역억제제 및 기관지확장제로 이루어진 그룹중에서 선택된 약제학적 조성물.
  8. 제2항에 있어서, 약제가 류프롤리드 아세테이트, Ac-D-2-Nal-D-4-ClPhe-D-3-Pal-Ser-N-MeTyr-D-Lys(Nic)-Leu-Lys(N-Isp)-Pro-D-Ala-NH2, N-[3-[5-(4-플루오로페닐메틸)-2-티에닐]-1-메틸-2-프로피닐]-N-하이드록시우레아, 사이클로스포린 및 이소프로테레놀로 이루어진 그룹중에서 선택된 약제학적 조성물.
  9. 제8항에 있어서, 분사제가 HFC-134a인 약제학적 조성물.
  10. 제9항에 있어서, 토코페롤이 0.001 내지 5중량%의 농도로 존재하는 약제학적 조성물.
  11. 현탁액에 입자 응집을 방지하기에 충분한 양의 토코페롤을 첨가함을 포함하여, 액상 비-클로로플루오로카본 에어로졸 분사제중의 약제 입자의 안정한 현탁액을 제조하는 방법.
  12. 제11항에 있어서, 분사제가 HFC-134a 및 HFC-227ea로 이루어진 그룹중에서 선택되는 방법.
  13. 제11항에 있어서, 토코페롤이 d-알파 토코페롤, dl-알파 토코페롤, d-알파 토코페롤 아세테이트, dl-알파 토코페롤 아세테이트, d-알파 토코페롤산 석시네이트 및 dl-알파 토코페롤산 석시네이트로 이루어진 그룹중에서 선택된 형태인 방법.
  14. 제12항 또는 제13항에 있어서, 약제가 류프롤리드 아세테이트, Ac-D-2-Nal-D-4-ClPhe-D-3-Pal-Ser-N-MeTyr-D-Lys(Nic)-Leu-Lys(N-Isp)-Pro-D-Ala-NH2, N-[3-[5-(4-플루오로페닐메틸)-2-티에닐]-1-메틸-2-프로피닐]-N-하이드록시우레아, 사이클로스포린 및 이소프로테레놀로 이루어진 그룹중에서 선택된 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019960705052A 1994-03-14 1995-03-02 비타민 E를 함유하는 에어로졸 약물 제형(Aerosol drug formulations containing vitamin'E) Ceased KR970701535A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21247294A 1994-03-14 1994-03-14
US08/212,472 1994-03-14
ITRM94U000063 1994-03-25
PCT/US1995/002764 WO1995024892A1 (en) 1994-03-14 1995-03-02 Aerosol drug formulations containing vitamin e

Publications (1)

Publication Number Publication Date
KR970701535A true KR970701535A (ko) 1997-04-12

Family

ID=22791169

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960705052A Ceased KR970701535A (ko) 1994-03-14 1995-03-02 비타민 E를 함유하는 에어로졸 약물 제형(Aerosol drug formulations containing vitamin'E)

Country Status (7)

Country Link
EP (1) EP0804157A1 (ko)
JP (1) JPH09510445A (ko)
KR (1) KR970701535A (ko)
AU (1) AU709783B2 (ko)
CA (1) CA2183557A1 (ko)
IL (1) IL112897A0 (ko)
WO (1) WO1995024892A1 (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
WO1998001147A1 (en) * 1996-07-08 1998-01-15 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6193954B1 (en) 1997-03-21 2001-02-27 Abbott Laboratories Formulations for pulmonary delivery of dopamine agonists
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
ES2364636T3 (es) 2001-12-19 2011-09-08 Novartis Ag Administración pulmonar de aminoglucósidos.
DE102006051512A1 (de) 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
HUT67449A (en) * 1991-06-10 1995-04-28 Schering Corp Aerosol formulations containing 1,1,1,2,3,3,3-heptafluoropropane
CA2111003A1 (en) * 1991-06-10 1992-12-23 Julianne Fassberg Non-chlorofluorocarbon aerosol formulations
ATE128350T1 (de) * 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
ES2159678T3 (es) * 1991-12-18 2001-10-16 Minnesota Mining & Mfg Formulaciones de aerosol en suspension.
DE4203306A1 (de) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh Asthma oder pulmonal-aerosolzubereitungen mit lecithin
US5301664A (en) * 1992-03-06 1994-04-12 Sievers Robert E Methods and apparatus for drug delivery using supercritical solutions
DE4230876A1 (de) * 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten

Also Published As

Publication number Publication date
JPH09510445A (ja) 1997-10-21
AU709783B2 (en) 1999-09-09
MX9604004A (es) 1997-12-31
CA2183557A1 (en) 1995-09-21
AU1980495A (en) 1995-10-03
IL112897A0 (en) 1995-06-29
WO1995024892A1 (en) 1995-09-21
EP0804157A1 (en) 1997-11-05

Similar Documents

Publication Publication Date Title
KR970701535A (ko) 비타민 E를 함유하는 에어로졸 약물 제형(Aerosol drug formulations containing vitamin'E)
US5798333A (en) Water-soluble concentrates containing cyclosporins
US6197335B1 (en) Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant
EP0977562B1 (en) Methods and compositions for delivery of taxanes
US5635159A (en) Aerosol drug formulations containing polyglycolyzed glycerides
KR20010053025A (ko) 가압 정량 흡입기 및 제약학적 분무 제제형
KR950007859A (ko) 경구 투여용 라파마이신 제형
DK0731688T3 (da) Aerosol-lægemiddelformuleringer til anvendelse med CFC-frie drivmidler
WO1996040089A3 (en) Aerosol drug formulations containing vegetable oils
KR960030948A (ko) 비강투여용 비무기 식염용액
KR900013964A (ko) 활성형 비타민 d₃류 제제용 조성물 및 이를 함유하는 안정한 활성형 비타민 d₃류 제제의 제조방법
US7872049B2 (en) Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate
KR930001903A (ko) 유비데카레논 경구용 수용액 제제
DK169566B1 (da) Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet
WO1998030204A1 (en) Pharmaceutical microemulsion preconcentrates comprising cyclosporins
US4406888A (en) Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
CA1112567A (en) Disodium cromoglycate self-propelling compositions
JPH09169642A (ja) テトラヒドロゾリン含有液剤
CA2185600A1 (en) Water-soluble concentrates containing cyclosporins
CA1288353C (en) Urea stabilized with a lactone in various pharmaceutical and cosmetic preparations
CN1353981A (zh) 速效抗心绞痛气雾剂及其制备方法
KR870003777A (ko) 조절된 방출성의 약학적 제제
CN119185562A (zh) 抑制二丁羟基甲苯含量降低的眼科用液体制剂
Dressler 6.1 Composition
NZ272653A (en) Pharmaceutical compositions comprising a cyclosporin dissolved in tocophersolan and a hydrophillic organic solvent

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19960912

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20000302

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20020430

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20020724

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20020430

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I